Julie Elizabeth Howell-Clemmer, APRN

Julie Howell-Clemmer practices at Santa Rosa HMA Physician Management in Milton, Florida.

Julie Howell-Clemmer's NPI, 1699482141, was assigned on November 3, 2022. Julie Howell-Clemmer holds Florida license APRN11021697.

Julie Howell-Clemmer's primary practice is Santa Rosa HMA Physician Management, at 6007 Berryhill Rd, Milton, FL 32570 in Santa Rosa County. The practice phone is (850) 994-6575.

Julie Howell-Clemmer's primary practice is Santa Rosa HMA Physician Management in Milton, Florida. Julie Howell-Clemmer is also affiliated with Santa Rosa Medical Center. The medical group on file is Santa Rosa Medical Group. Dmand AI also links Julie Howell-Clemmer to 1 more hospital, 3 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Julie Howell-Clemmer practices, 6 sites in all. Vendor and product names are available with a free account.

General practice is Julie Howell-Clemmer's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Julie Howell-Clemmer is licensed in Florida.

Dmand AI lists anxiety, arthritis, asthma, chronic diabetes, chronic kidney disease, chronic nasal allergies, chronic obstructive pulmonary disease (COPD) and diabetic emergency among the conditions Julie Howell-Clemmer treats.

CMS data shows 1,310 Medicare services from Julie Howell-Clemmer across 12 procedure codes in 2024, for 221 Medicare patients. Medicare paid $68,369 for them. Every service was in an office.

CMS counts 221 Medicare patients who saw Julie Howell-Clemmer in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Julie Howell-Clemmer's median patient age at 67, with 66% women.

In 2024, Julie Howell-Clemmer wrote 5,690 Medicare Part D claims for 348 patients. 86% of them were for generic drugs. CMS names the drug for 4,978 of them, across 112 drugs with 11 or more claims each, at $361,182 in total drug cost. In 2023, CMS named 1,172 claims across 50 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Julie Howell-Clemmer for performance year 2024, reported through an alternative payment model (APM). Julie Howell-Clemmer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Julie Howell-Clemmer as offering telehealth.

CMS Open Payments shows 57 general payments to Julie Howell-Clemmer from 13 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $266.